Adivo

About:

Adivo is a veterinary biotechnology company .

Website: https://adivo.vet/

Twitter/X: AdivoVet

Top Investors: European Innovation Council, HTGF | High-Tech Gruenderfonds, OCCIDENT, MorphoSys

Description:

adivo is a veterinary biotechnology company developing therapeutic antibodies for pets. The focus is on the treatment of serious diseases in dogs with the potential to offer therapies for other species as well. The antibody selection is based on a new, fully synthetic, dog-specific drug library that can be used to isolate antibodies with optimal properties using phage display technology. adivo is a spin-off of MorphoSys AG. Many years of expertise in the development of human therapeutic antibodies transfer the adivo team into veterinary medicine.